Search
English
Login
ALS expands pharmaceutical chemistry capabilities in India with new Hyderabad laboratory
ALS’ pharmaceutical business has expanded its chemistry capabilities in India with the opening of a new synthesis laboratory in Hyderabad, connecting scalable chemistry resources in India with Nuvisan’s scientific expertise and client engagement.
Officially inaugurated on 25 August, the new laboratory strengthens ALS’ ability to support research for global pharmaceutical clients across the drug discovery and development value chain. By connecting capabilities across India and Europe, ALS can provide greater flexibility and capacity, coordinated project delivery and consistent scientific, EHS and operational standards.
Rickard Olofsson, Executive General Manager Pharmaceutical, said the investment strengthens ALS’ ability to support global pharmaceutical clients through a more streamlined operating model.
“Our team in Hyderabad adds scalable chemistry resources, while Nuvisan provides the scientific expertise, quality oversight and client engagement that are central to the offering. Together, we can provide high-quality, flexible support across geographies without adding complexity for our clients,” Rickard said.
The investment comes as global pharmaceutical companies continue to expand their capability centres in India. As one of the country’s leading pharmaceutical and technology hubs, Hyderabad places ALS closer to our clients and a growing ecosystem of pharmaceutical research and development.
Arun Janakiraman, General Manager Pharmaceutical in APAC said the investment reflects the changing pharmaceutical landscape in India and the opportunities this is creating for ALS and its clients.
“We’re seeing global pharmaceutical companies build increasingly sophisticated capabilities in India, particularly in Hyderabad,” Arun said.
“That is creating new opportunities for how and where pharmaceutical research is delivered. Having our own chemistry capability here means we can be part of that evolution and respond to clients as their requirements continue to develop.”
The new Hyderabad laboratory complements Nuvisan’s established European capabilities, expanding ALS’ chemistry expertise and capacity across regions to provide clients with high-quality, flexible support across the drug discovery and development value chain.
ALS is a global leader in testing, providing comprehensive testing solutions to clients in a wide range of industries around the world. Using state-of-the-art technologies and innovative methodologies, our dedicated international teams deliver the highest-quality testing services and personalised solutions supported by local expertise. We help our clients leverage the power of data-driven insights for a safer and healthier world.